These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 10163573

  • 21. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
    Ismaila AS, Risebrough N, Li C, Corriveau D, Hawkins N, FitzGerald JM, Su Z.
    Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
    [Abstract] [Full Text] [Related]

  • 22. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
    Galant SP, Lawrence M, Meltzer EO, Tomasko M, Baker KA, Kellerman DJ.
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
    Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, Kellerman DJ.
    J Asthma; 1996 Mar; 33(4):265-74. PubMed ID: 8707781
    [Abstract] [Full Text] [Related]

  • 31. Improvement in health care utilization and pulmonary function with fluticasone propionate in patients with steroid-dependent asthma at a National Asthma Referral Center.
    Wenzel SE, Morgan K, Griffin R, Stanford R, Edwards L, Wamboldt FS, Rogenes P.
    J Asthma; 2001 Aug; 38(5):405-12. PubMed ID: 11515977
    [Abstract] [Full Text] [Related]

  • 32. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W, Wolfe J, Storms W, Srebro S, Edwards L, Johnson M, Bowers BW, Rogenes PR, Rickard K.
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the cost-effectiveness of budesonide and sodium cromoglycate in the management of childhood asthma in everyday clinical practice.
    Andersson F, Kjellman M, Forsberg G, Möller C, Arheden L.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):537-44. PubMed ID: 11379805
    [Abstract] [Full Text] [Related]

  • 34. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
    J Asthma; 2007 May; 44(6):437-41. PubMed ID: 17654129
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I, Tworek D, Vanderbist F, Bocheńska-Marciniak M, Kuna P.
    Pneumonol Alergol Pol; 2013 May; 81(6):527-36. PubMed ID: 24142782
    [Abstract] [Full Text] [Related]

  • 36. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
    O'Connor B, Bonnaud G, Haahtela T, Luna JM, Querfurt H, Wegener T, Lutsky BN.
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children].
    Rely K, McQuire SE, Alexandre PK, Escudero GS.
    Value Health; 2011 Apr; 14(5 Suppl 1):S43-7. PubMed ID: 21839898
    [Abstract] [Full Text] [Related]

  • 39. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group.
    Sheffer AL, LaForce C, Chervinsky P, Pearlman D, Schaberg A.
    J Fam Pract; 1996 Apr; 42(4):369-75. PubMed ID: 8627205
    [Abstract] [Full Text] [Related]

  • 40. Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges.
    Navaratnam P, Friedman HS, Urdaneta E.
    Curr Med Res Opin; 2009 Dec; 25(12):2895-901. PubMed ID: 19821655
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.